The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Penem Antibiotics Market Research Report 2025
Synopsis
Penem Antibiotics (Carbapenems) are a class of very effective antibiotic agents most commonly used for treatment of severe bacterial infections. This class of antibiotics is usually reserved for known or suspected multidrug-resistant (MDR) bacterial infections. Similar to penicillins and cephalosporins, carbapenems are members of the beta-lactam antibiotics drug class, which kill bacteria by binding to penicillin-binding proteins, thus inhibiting bacterial cell wall synthesis. However, these agents individually exhibit a broader spectrum of activity compared to most cephalosporins and penicillins. Furthermore, carbapenems are typically unaffected by emerging antibiotic resistance, even to other beta-lactams.
The global Penem Antibiotics market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of %during the forecast period 2024-2030.
North American market for Penem Antibiotics is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Penem Antibiotics is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The global market for Penem Antibiotics in Hospital is estimated to increase from $ million in 2023 to $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global companies of Penem Antibiotics include Sumitomo Pharma, Merck Sharp & Dohme, Savior Lifetec, ACS Dobfar, Pfizer, Eugia Pharma, Venus Remedies, Sun Pharmaceutical, JW Pharmaceutical, Aurobindo Pharma, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Penem Antibiotics, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Penem Antibiotics.
The Penem Antibiotics market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Penem Antibiotics market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Penem Antibiotics companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Sumitomo Pharma
Merck Sharp & Dohme
Savior Lifetec
ACS Dobfar
Pfizer
Eugia Pharma
Venus Remedies
Sun Pharmaceutical
JW Pharmaceutical
Aurobindo Pharma
Daiichi Sankyo
Maruho
Taiwan Biotech
Shenzhen Haibin Pharmaceutical
Zhejiang Hisun Pharmaceutical
Cspc Holdings
Zhuhai United Laboratories
Haikou Pharmaceutical Factory
Chia Tai Tianqing Pharmaceuticals
Jiangsu Simcere Pharmaceutical
Segment by Type
Meropenem
Imipenem
Biapenem
Ertapenem
Others
Segment by Application
Hospital
Clinic
Others
By Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Rest of Europe
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Penem Antibiotics company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Penem Antibiotics (Carbapenems) are a class of very effective antibiotic agents most commonly used for treatment of severe bacterial infections. This class of antibiotics is usually reserved for known or suspected multidrug-resistant (MDR) bacterial infections. Similar to penicillins and cephalosporins, carbapenems are members of the beta-lactam antibiotics drug class, which kill bacteria by binding to penicillin-binding proteins, thus inhibiting bacterial cell wall synthesis. However, these agents individually exhibit a broader spectrum of activity compared to most cephalosporins and penicillins. Furthermore, carbapenems are typically unaffected by emerging antibiotic resistance, even to other beta-lactams.
The global Penem Antibiotics market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of %during the forecast period 2024-2030.
North American market for Penem Antibiotics is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Penem Antibiotics is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The global market for Penem Antibiotics in Hospital is estimated to increase from $ million in 2023 to $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global companies of Penem Antibiotics include Sumitomo Pharma, Merck Sharp & Dohme, Savior Lifetec, ACS Dobfar, Pfizer, Eugia Pharma, Venus Remedies, Sun Pharmaceutical, JW Pharmaceutical, Aurobindo Pharma, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Penem Antibiotics, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Penem Antibiotics.
The Penem Antibiotics market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Penem Antibiotics market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Penem Antibiotics companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Sumitomo Pharma
Merck Sharp & Dohme
Savior Lifetec
ACS Dobfar
Pfizer
Eugia Pharma
Venus Remedies
Sun Pharmaceutical
JW Pharmaceutical
Aurobindo Pharma
Daiichi Sankyo
Maruho
Taiwan Biotech
Shenzhen Haibin Pharmaceutical
Zhejiang Hisun Pharmaceutical
Cspc Holdings
Zhuhai United Laboratories
Haikou Pharmaceutical Factory
Chia Tai Tianqing Pharmaceuticals
Jiangsu Simcere Pharmaceutical
Segment by Type
Meropenem
Imipenem
Biapenem
Ertapenem
Others
Segment by Application
Hospital
Clinic
Others
By Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Rest of Europe
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Penem Antibiotics company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Index1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Penem Antibiotics Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 Meropenem
1.2.3 Imipenem
1.2.4 Biapenem
1.2.5 Ertapenem
1.2.6 Others
1.3 Market by Application
1.3.1 Global Penem Antibiotics Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Hospital
1.3.3 Clinic
1.3.4 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Penem Antibiotics Market Perspective (2019-2030)
2.2 Global Penem Antibiotics Growth Trends by Region
2.2.1 Global Penem Antibiotics Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Penem Antibiotics Historic Market Size by Region (2019-2024)
2.2.3 Penem Antibiotics Forecasted Market Size by Region (2025-2030)
2.3 Penem Antibiotics Market Dynamics
2.3.1 Penem Antibiotics Industry Trends
2.3.2 Penem Antibiotics Market Drivers
2.3.3 Penem Antibiotics Market Challenges
2.3.4 Penem Antibiotics Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Penem Antibiotics Players by Revenue
3.1.1 Global Top Penem Antibiotics Players by Revenue (2019-2024)
3.1.2 Global Penem Antibiotics Revenue Market Share by Players (2019-2024)
3.2 Global Penem Antibiotics Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by Penem Antibiotics Revenue
3.4 Global Penem Antibiotics Market Concentration Ratio
3.4.1 Global Penem Antibiotics Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Penem Antibiotics Revenue in 2023
3.5 Global Key Players of Penem Antibiotics Head office and Area Served
3.6 Global Key Players of Penem Antibiotics, Product and Application
3.7 Global Key Players of Penem Antibiotics, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Penem Antibiotics Breakdown Data by Type
4.1 Global Penem Antibiotics Historic Market Size by Type (2019-2024)
4.2 Global Penem Antibiotics Forecasted Market Size by Type (2025-2030)
5 Penem Antibiotics Breakdown Data by Application
5.1 Global Penem Antibiotics Historic Market Size by Application (2019-2024)
5.2 Global Penem Antibiotics Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Penem Antibiotics Market Size (2019-2030)
6.2 North America Penem Antibiotics Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America Penem Antibiotics Market Size by Country (2019-2024)
6.4 North America Penem Antibiotics Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Penem Antibiotics Market Size (2019-2030)
7.2 Europe Penem Antibiotics Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe Penem Antibiotics Market Size by Country (2019-2024)
7.4 Europe Penem Antibiotics Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Penem Antibiotics Market Size (2019-2030)
8.2 Asia-Pacific Penem Antibiotics Market Growth Rate by Country: 2019 VS 2023 VS 2030
8.3 Asia-Pacific Penem Antibiotics Market Size by Region (2019-2024)
8.4 Asia-Pacific Penem Antibiotics Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Penem Antibiotics Market Size (2019-2030)
9.2 Latin America Penem Antibiotics Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America Penem Antibiotics Market Size by Country (2019-2024)
9.4 Latin America Penem Antibiotics Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Penem Antibiotics Market Size (2019-2030)
10.2 Middle East & Africa Penem Antibiotics Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa Penem Antibiotics Market Size by Country (2019-2024)
10.4 Middle East & Africa Penem Antibiotics Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Sumitomo Pharma
11.1.1 Sumitomo Pharma Company Details
11.1.2 Sumitomo Pharma Business Overview
11.1.3 Sumitomo Pharma Penem Antibiotics Introduction
11.1.4 Sumitomo Pharma Revenue in Penem Antibiotics Business (2019-2024)
11.1.5 Sumitomo Pharma Recent Development
11.2 Merck Sharp & Dohme
11.2.1 Merck Sharp & Dohme Company Details
11.2.2 Merck Sharp & Dohme Business Overview
11.2.3 Merck Sharp & Dohme Penem Antibiotics Introduction
11.2.4 Merck Sharp & Dohme Revenue in Penem Antibiotics Business (2019-2024)
11.2.5 Merck Sharp & Dohme Recent Development
11.3 Savior Lifetec
11.3.1 Savior Lifetec Company Details
11.3.2 Savior Lifetec Business Overview
11.3.3 Savior Lifetec Penem Antibiotics Introduction
11.3.4 Savior Lifetec Revenue in Penem Antibiotics Business (2019-2024)
11.3.5 Savior Lifetec Recent Development
11.4 ACS Dobfar
11.4.1 ACS Dobfar Company Details
11.4.2 ACS Dobfar Business Overview
11.4.3 ACS Dobfar Penem Antibiotics Introduction
11.4.4 ACS Dobfar Revenue in Penem Antibiotics Business (2019-2024)
11.4.5 ACS Dobfar Recent Development
11.5 Pfizer
11.5.1 Pfizer Company Details
11.5.2 Pfizer Business Overview
11.5.3 Pfizer Penem Antibiotics Introduction
11.5.4 Pfizer Revenue in Penem Antibiotics Business (2019-2024)
11.5.5 Pfizer Recent Development
11.6 Eugia Pharma
11.6.1 Eugia Pharma Company Details
11.6.2 Eugia Pharma Business Overview
11.6.3 Eugia Pharma Penem Antibiotics Introduction
11.6.4 Eugia Pharma Revenue in Penem Antibiotics Business (2019-2024)
11.6.5 Eugia Pharma Recent Development
11.7 Venus Remedies
11.7.1 Venus Remedies Company Details
11.7.2 Venus Remedies Business Overview
11.7.3 Venus Remedies Penem Antibiotics Introduction
11.7.4 Venus Remedies Revenue in Penem Antibiotics Business (2019-2024)
11.7.5 Venus Remedies Recent Development
11.8 Sun Pharmaceutical
11.8.1 Sun Pharmaceutical Company Details
11.8.2 Sun Pharmaceutical Business Overview
11.8.3 Sun Pharmaceutical Penem Antibiotics Introduction
11.8.4 Sun Pharmaceutical Revenue in Penem Antibiotics Business (2019-2024)
11.8.5 Sun Pharmaceutical Recent Development
11.9 JW Pharmaceutical
11.9.1 JW Pharmaceutical Company Details
11.9.2 JW Pharmaceutical Business Overview
11.9.3 JW Pharmaceutical Penem Antibiotics Introduction
11.9.4 JW Pharmaceutical Revenue in Penem Antibiotics Business (2019-2024)
11.9.5 JW Pharmaceutical Recent Development
11.10 Aurobindo Pharma
11.10.1 Aurobindo Pharma Company Details
11.10.2 Aurobindo Pharma Business Overview
11.10.3 Aurobindo Pharma Penem Antibiotics Introduction
11.10.4 Aurobindo Pharma Revenue in Penem Antibiotics Business (2019-2024)
11.10.5 Aurobindo Pharma Recent Development
11.11 Daiichi Sankyo
11.11.1 Daiichi Sankyo Company Details
11.11.2 Daiichi Sankyo Business Overview
11.11.3 Daiichi Sankyo Penem Antibiotics Introduction
11.11.4 Daiichi Sankyo Revenue in Penem Antibiotics Business (2019-2024)
11.11.5 Daiichi Sankyo Recent Development
11.12 Maruho
11.12.1 Maruho Company Details
11.12.2 Maruho Business Overview
11.12.3 Maruho Penem Antibiotics Introduction
11.12.4 Maruho Revenue in Penem Antibiotics Business (2019-2024)
11.12.5 Maruho Recent Development
11.13 Taiwan Biotech
11.13.1 Taiwan Biotech Company Details
11.13.2 Taiwan Biotech Business Overview
11.13.3 Taiwan Biotech Penem Antibiotics Introduction
11.13.4 Taiwan Biotech Revenue in Penem Antibiotics Business (2019-2024)
11.13.5 Taiwan Biotech Recent Development
11.14 Shenzhen Haibin Pharmaceutical
11.14.1 Shenzhen Haibin Pharmaceutical Company Details
11.14.2 Shenzhen Haibin Pharmaceutical Business Overview
11.14.3 Shenzhen Haibin Pharmaceutical Penem Antibiotics Introduction
11.14.4 Shenzhen Haibin Pharmaceutical Revenue in Penem Antibiotics Business (2019-2024)
11.14.5 Shenzhen Haibin Pharmaceutical Recent Development
11.15 Zhejiang Hisun Pharmaceutical
11.15.1 Zhejiang Hisun Pharmaceutical Company Details
11.15.2 Zhejiang Hisun Pharmaceutical Business Overview
11.15.3 Zhejiang Hisun Pharmaceutical Penem Antibiotics Introduction
11.15.4 Zhejiang Hisun Pharmaceutical Revenue in Penem Antibiotics Business (2019-2024)
11.15.5 Zhejiang Hisun Pharmaceutical Recent Development
11.16 Cspc Holdings
11.16.1 Cspc Holdings Company Details
11.16.2 Cspc Holdings Business Overview
11.16.3 Cspc Holdings Penem Antibiotics Introduction
11.16.4 Cspc Holdings Revenue in Penem Antibiotics Business (2019-2024)
11.16.5 Cspc Holdings Recent Development
11.17 Zhuhai United Laboratories
11.17.1 Zhuhai United Laboratories Company Details
11.17.2 Zhuhai United Laboratories Business Overview
11.17.3 Zhuhai United Laboratories Penem Antibiotics Introduction
11.17.4 Zhuhai United Laboratories Revenue in Penem Antibiotics Business (2019-2024)
11.17.5 Zhuhai United Laboratories Recent Development
11.18 Haikou Pharmaceutical Factory
11.18.1 Haikou Pharmaceutical Factory Company Details
11.18.2 Haikou Pharmaceutical Factory Business Overview
11.18.3 Haikou Pharmaceutical Factory Penem Antibiotics Introduction
11.18.4 Haikou Pharmaceutical Factory Revenue in Penem Antibiotics Business (2019-2024)
11.18.5 Haikou Pharmaceutical Factory Recent Development
11.19 Chia Tai Tianqing Pharmaceuticals
11.19.1 Chia Tai Tianqing Pharmaceuticals Company Details
11.19.2 Chia Tai Tianqing Pharmaceuticals Business Overview
11.19.3 Chia Tai Tianqing Pharmaceuticals Penem Antibiotics Introduction
11.19.4 Chia Tai Tianqing Pharmaceuticals Revenue in Penem Antibiotics Business (2019-2024)
11.19.5 Chia Tai Tianqing Pharmaceuticals Recent Development
11.20 Jiangsu Simcere Pharmaceutical
11.20.1 Jiangsu Simcere Pharmaceutical Company Details
11.20.2 Jiangsu Simcere Pharmaceutical Business Overview
11.20.3 Jiangsu Simcere Pharmaceutical Penem Antibiotics Introduction
11.20.4 Jiangsu Simcere Pharmaceutical Revenue in Penem Antibiotics Business (2019-2024)
11.20.5 Jiangsu Simcere Pharmaceutical Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
List of TablesList of Tables
Table 1. Global Penem Antibiotics Market Size Growth Rate by Type (US$ Million): 2019 VS 2023 VS 2030
Table 2. Key Players of Meropenem
Table 3. Key Players of Imipenem
Table 4. Key Players of Biapenem
Table 5. Key Players of Ertapenem
Table 6. Key Players of Others
Table 7. Global Penem Antibiotics Market Size Growth by Application (US$ Million): 2019 VS 2023 VS 2030
Table 8. Global Penem Antibiotics Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Table 9. Global Penem Antibiotics Market Size by Region (2019-2024) & (US$ Million)
Table 10. Global Penem Antibiotics Market Share by Region (2019-2024)
Table 11. Global Penem Antibiotics Forecasted Market Size by Region (2025-2030) & (US$ Million)
Table 12. Global Penem Antibiotics Market Share by Region (2025-2030)
Table 13. Penem Antibiotics Market Trends
Table 14. Penem Antibiotics Market Drivers
Table 15. Penem Antibiotics Market Challenges
Table 16. Penem Antibiotics Market Restraints
Table 17. Global Penem Antibiotics Revenue by Players (2019-2024) & (US$ Million)
Table 18. Global Penem Antibiotics Market Share by Players (2019-2024)
Table 19. Global Top Penem Antibiotics Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Penem Antibiotics as of 2023)
Table 20. Ranking of Global Top Penem Antibiotics Companies by Revenue (US$ Million) in 2023
Table 21. Global 5 Largest Players Market Share by Penem Antibiotics Revenue (CR5 and HHI) & (2019-2024)
Table 22. Global Key Players of Penem Antibiotics, Headquarters and Area Served
Table 23. Global Key Players of Penem Antibiotics, Product and Application
Table 24. Global Key Players of Penem Antibiotics, Date of Enter into This Industry
Table 25. Mergers & Acquisitions, Expansion Plans
Table 26. Global Penem Antibiotics Market Size by Type (2019-2024) & (US$ Million)
Table 27. Global Penem Antibiotics Revenue Market Share by Type (2019-2024)
Table 28. Global Penem Antibiotics Forecasted Market Size by Type (2025-2030) & (US$ Million)
Table 29. Global Penem Antibiotics Revenue Market Share by Type (2025-2030)
Table 30. Global Penem Antibiotics Market Size by Application (2019-2024) & (US$ Million)
Table 31. Global Penem Antibiotics Revenue Market Share by Application (2019-2024)
Table 32. Global Penem Antibiotics Forecasted Market Size by Application (2025-2030) & (US$ Million)
Table 33. Global Penem Antibiotics Revenue Market Share by Application (2025-2030)
Table 34. North America Penem Antibiotics Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 35. North America Penem Antibiotics Market Size by Country (2019-2024) & (US$ Million)
Table 36. North America Penem Antibiotics Market Size by Country (2025-2030) & (US$ Million)
Table 37. Europe Penem Antibiotics Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 38. Europe Penem Antibiotics Market Size by Country (2019-2024) & (US$ Million)
Table 39. Europe Penem Antibiotics Market Size by Country (2025-2030) & (US$ Million)
Table 40. Asia-Pacific Penem Antibiotics Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 41. Asia-Pacific Penem Antibiotics Market Size by Region (2019-2024) & (US$ Million)
Table 42. Asia-Pacific Penem Antibiotics Market Size by Region (2025-2030) & (US$ Million)
Table 43. Latin America Penem Antibiotics Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 44. Latin America Penem Antibiotics Market Size by Country (2019-2024) & (US$ Million)
Table 45. Latin America Penem Antibiotics Market Size by Country (2025-2030) & (US$ Million)
Table 46. Middle East & Africa Penem Antibiotics Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 47. Middle East & Africa Penem Antibiotics Market Size by Country (2019-2024) & (US$ Million)
Table 48. Middle East & Africa Penem Antibiotics Market Size by Country (2025-2030) & (US$ Million)
Table 49. Sumitomo Pharma Company Details
Table 50. Sumitomo Pharma Business Overview
Table 51. Sumitomo Pharma Penem Antibiotics Product
Table 52. Sumitomo Pharma Revenue in Penem Antibiotics Business (2019-2024) & (US$ Million)
Table 53. Sumitomo Pharma Recent Development
Table 54. Merck Sharp & Dohme Company Details
Table 55. Merck Sharp & Dohme Business Overview
Table 56. Merck Sharp & Dohme Penem Antibiotics Product
Table 57. Merck Sharp & Dohme Revenue in Penem Antibiotics Business (2019-2024) & (US$ Million)
Table 58. Merck Sharp & Dohme Recent Development
Table 59. Savior Lifetec Company Details
Table 60. Savior Lifetec Business Overview
Table 61. Savior Lifetec Penem Antibiotics Product
Table 62. Savior Lifetec Revenue in Penem Antibiotics Business (2019-2024) & (US$ Million)
Table 63. Savior Lifetec Recent Development
Table 64. ACS Dobfar Company Details
Table 65. ACS Dobfar Business Overview
Table 66. ACS Dobfar Penem Antibiotics Product
Table 67. ACS Dobfar Revenue in Penem Antibiotics Business (2019-2024) & (US$ Million)
Table 68. ACS Dobfar Recent Development
Table 69. Pfizer Company Details
Table 70. Pfizer Business Overview
Table 71. Pfizer Penem Antibiotics Product
Table 72. Pfizer Revenue in Penem Antibiotics Business (2019-2024) & (US$ Million)
Table 73. Pfizer Recent Development
Table 74. Eugia Pharma Company Details
Table 75. Eugia Pharma Business Overview
Table 76. Eugia Pharma Penem Antibiotics Product
Table 77. Eugia Pharma Revenue in Penem Antibiotics Business (2019-2024) & (US$ Million)
Table 78. Eugia Pharma Recent Development
Table 79. Venus Remedies Company Details
Table 80. Venus Remedies Business Overview
Table 81. Venus Remedies Penem Antibiotics Product
Table 82. Venus Remedies Revenue in Penem Antibiotics Business (2019-2024) & (US$ Million)
Table 83. Venus Remedies Recent Development
Table 84. Sun Pharmaceutical Company Details
Table 85. Sun Pharmaceutical Business Overview
Table 86. Sun Pharmaceutical Penem Antibiotics Product
Table 87. Sun Pharmaceutical Revenue in Penem Antibiotics Business (2019-2024) & (US$ Million)
Table 88. Sun Pharmaceutical Recent Development
Table 89. JW Pharmaceutical Company Details
Table 90. JW Pharmaceutical Business Overview
Table 91. JW Pharmaceutical Penem Antibiotics Product
Table 92. JW Pharmaceutical Revenue in Penem Antibiotics Business (2019-2024) & (US$ Million)
Table 93. JW Pharmaceutical Recent Development
Table 94. Aurobindo Pharma Company Details
Table 95. Aurobindo Pharma Business Overview
Table 96. Aurobindo Pharma Penem Antibiotics Product
Table 97. Aurobindo Pharma Revenue in Penem Antibiotics Business (2019-2024) & (US$ Million)
Table 98. Aurobindo Pharma Recent Development
Table 99. Daiichi Sankyo Company Details
Table 100. Daiichi Sankyo Business Overview
Table 101. Daiichi Sankyo Penem Antibiotics Product
Table 102. Daiichi Sankyo Revenue in Penem Antibiotics Business (2019-2024) & (US$ Million)
Table 103. Daiichi Sankyo Recent Development
Table 104. Maruho Company Details
Table 105. Maruho Business Overview
Table 106. Maruho Penem Antibiotics Product
Table 107. Maruho Revenue in Penem Antibiotics Business (2019-2024) & (US$ Million)
Table 108. Maruho Recent Development
Table 109. Taiwan Biotech Company Details
Table 110. Taiwan Biotech Business Overview
Table 111. Taiwan Biotech Penem Antibiotics Product
Table 112. Taiwan Biotech Revenue in Penem Antibiotics Business (2019-2024) & (US$ Million)
Table 113. Taiwan Biotech Recent Development
Table 114. Shenzhen Haibin Pharmaceutical Company Details
Table 115. Shenzhen Haibin Pharmaceutical Business Overview
Table 116. Shenzhen Haibin Pharmaceutical Penem Antibiotics Product
Table 117. Shenzhen Haibin Pharmaceutical Revenue in Penem Antibiotics Business (2019-2024) & (US$ Million)
Table 118. Shenzhen Haibin Pharmaceutical Recent Development
Table 119. Zhejiang Hisun Pharmaceutical Company Details
Table 120. Zhejiang Hisun Pharmaceutical Business Overview
Table 121. Zhejiang Hisun Pharmaceutical Penem Antibiotics Product
Table 122. Zhejiang Hisun Pharmaceutical Revenue in Penem Antibiotics Business (2019-2024) & (US$ Million)
Table 123. Zhejiang Hisun Pharmaceutical Recent Development
Table 124. Cspc Holdings Company Details
Table 125. Cspc Holdings Business Overview
Table 126. Cspc Holdings Penem Antibiotics Product
Table 127. Cspc Holdings Revenue in Penem Antibiotics Business (2019-2024) & (US$ Million)
Table 128. Cspc Holdings Recent Development
Table 129. Zhuhai United Laboratories Company Details
Table 130. Zhuhai United Laboratories Business Overview
Table 131. Zhuhai United Laboratories Penem Antibiotics Product
Table 132. Zhuhai United Laboratories Revenue in Penem Antibiotics Business (2019-2024) & (US$ Million)
Table 133. Zhuhai United Laboratories Recent Development
Table 134. Haikou Pharmaceutical Factory Company Details
Table 135. Haikou Pharmaceutical Factory Business Overview
Table 136. Haikou Pharmaceutical Factory Penem Antibiotics Product
Table 137. Haikou Pharmaceutical Factory Revenue in Penem Antibiotics Business (2019-2024) & (US$ Million)
Table 138. Haikou Pharmaceutical Factory Recent Development
Table 139. Chia Tai Tianqing Pharmaceuticals Company Details
Table 140. Chia Tai Tianqing Pharmaceuticals Business Overview
Table 141. Chia Tai Tianqing Pharmaceuticals Penem Antibiotics Product
Table 142. Chia Tai Tianqing Pharmaceuticals Revenue in Penem Antibiotics Business (2019-2024) & (US$ Million)
Table 143. Chia Tai Tianqing Pharmaceuticals Recent Development
Table 144. Jiangsu Simcere Pharmaceutical Company Details
Table 145. Jiangsu Simcere Pharmaceutical Business Overview
Table 146. Jiangsu Simcere Pharmaceutical Penem Antibiotics Product
Table 147. Jiangsu Simcere Pharmaceutical Revenue in Penem Antibiotics Business (2019-2024) & (US$ Million)
Table 148. Jiangsu Simcere Pharmaceutical Recent Development
Table 149. Research Programs/Design for This Report
Table 150. Key Data Information from Secondary Sources
Table 151. Key Data Information from Primary Sources
Table 152. Authors List of This Report
List of Figures
Figure 1. Penem Antibiotics Picture
Figure 2. Global Penem Antibiotics Market Size Comparison by Type (2024-2030) & (US$ Million)
Figure 3. Global Penem Antibiotics Market Share by Type: 2023 VS 2030
Figure 4. Meropenem Features
Figure 5. Imipenem Features
Figure 6. Biapenem Features
Figure 7. Ertapenem Features
Figure 8. Others Features
Figure 9. Global Penem Antibiotics Market Size by Application (2024-2030) & (US$ Million)
Figure 10. Global Penem Antibiotics Market Share by Application: 2023 VS 2030
Figure 11. Hospital Case Studies
Figure 12. Clinic Case Studies
Figure 13. Others Case Studies
Figure 14. Penem Antibiotics Report Years Considered
Figure 15. Global Penem Antibiotics Market Size (US$ Million), Year-over-Year: 2019-2030
Figure 16. Global Penem Antibiotics Market Size, (US$ Million), 2019 VS 2023 VS 2030
Figure 17. Global Penem Antibiotics Market Share by Region: 2023 VS 2030
Figure 18. Global Penem Antibiotics Market Share by Players in 2023
Figure 19. Global Top Penem Antibiotics Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Penem Antibiotics as of 2023)
Figure 20. The Top 10 and 5 Players Market Share by Penem Antibiotics Revenue in 2023
Figure 21. North America Penem Antibiotics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 22. North America Penem Antibiotics Market Share by Country (2019-2030)
Figure 23. United States Penem Antibiotics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 24. Canada Penem Antibiotics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 25. Europe Penem Antibiotics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 26. Europe Penem Antibiotics Market Share by Country (2019-2030)
Figure 27. Germany Penem Antibiotics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 28. France Penem Antibiotics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 29. U.K. Penem Antibiotics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 30. Italy Penem Antibiotics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 31. Russia Penem Antibiotics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 32. Nordic Countries Penem Antibiotics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 33. Asia-Pacific Penem Antibiotics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 34. Asia-Pacific Penem Antibiotics Market Share by Region (2019-2030)
Figure 35. China Penem Antibiotics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 36. Japan Penem Antibiotics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 37. South Korea Penem Antibiotics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 38. Southeast Asia Penem Antibiotics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 39. India Penem Antibiotics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 40. Australia Penem Antibiotics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 41. Latin America Penem Antibiotics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 42. Latin America Penem Antibiotics Market Share by Country (2019-2030)
Figure 43. Mexico Penem Antibiotics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 44. Brazil Penem Antibiotics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 45. Middle East & Africa Penem Antibiotics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 46. Middle East & Africa Penem Antibiotics Market Share by Country (2019-2030)
Figure 47. Turkey Penem Antibiotics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 48. Saudi Arabia Penem Antibiotics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 49. UAE Penem Antibiotics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 50. Sumitomo Pharma Revenue Growth Rate in Penem Antibiotics Business (2019-2024)
Figure 51. Merck Sharp & Dohme Revenue Growth Rate in Penem Antibiotics Business (2019-2024)
Figure 52. Savior Lifetec Revenue Growth Rate in Penem Antibiotics Business (2019-2024)
Figure 53. ACS Dobfar Revenue Growth Rate in Penem Antibiotics Business (2019-2024)
Figure 54. Pfizer Revenue Growth Rate in Penem Antibiotics Business (2019-2024)
Figure 55. Eugia Pharma Revenue Growth Rate in Penem Antibiotics Business (2019-2024)
Figure 56. Venus Remedies Revenue Growth Rate in Penem Antibiotics Business (2019-2024)
Figure 57. Sun Pharmaceutical Revenue Growth Rate in Penem Antibiotics Business (2019-2024)
Figure 58. JW Pharmaceutical Revenue Growth Rate in Penem Antibiotics Business (2019-2024)
Figure 59. Aurobindo Pharma Revenue Growth Rate in Penem Antibiotics Business (2019-2024)
Figure 60. Daiichi Sankyo Revenue Growth Rate in Penem Antibiotics Business (2019-2024)
Figure 61. Maruho Revenue Growth Rate in Penem Antibiotics Business (2019-2024)
Figure 62. Taiwan Biotech Revenue Growth Rate in Penem Antibiotics Business (2019-2024)
Figure 63. Shenzhen Haibin Pharmaceutical Revenue Growth Rate in Penem Antibiotics Business (2019-2024)
Figure 64. Zhejiang Hisun Pharmaceutical Revenue Growth Rate in Penem Antibiotics Business (2019-2024)
Figure 65. Cspc Holdings Revenue Growth Rate in Penem Antibiotics Business (2019-2024)
Figure 66. Zhuhai United Laboratories Revenue Growth Rate in Penem Antibiotics Business (2019-2024)
Figure 67. Haikou Pharmaceutical Factory Revenue Growth Rate in Penem Antibiotics Business (2019-2024)
Figure 68. Chia Tai Tianqing Pharmaceuticals Revenue Growth Rate in Penem Antibiotics Business (2019-2024)
Figure 69. Jiangsu Simcere Pharmaceutical Revenue Growth Rate in Penem Antibiotics Business (2019-2024)
Figure 70. Bottom-up and Top-down Approaches for This Report
Figure 71. Data Triangulation
Figure 72. Key Executives Interviewed
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
